GlobeNewsWire
23 Sept 2026, 00:46 UTC · 1h ago
Verdict
Headline takes no side. We score EBS −1.00 across three claims — strongly bearish.
−1.00strongly bearish
More negative than 95% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 1 new · 2 priced in
Pomerantz LLP is investigating Emergent BioSolutions for potential securities fraud or unlawful business practices.
Newpress release dated Sept. 22, 2026
More negative than 78% of claims this week
Emergent BioSolutions reported a $191.3 million non-cash impairment charge on the NARCAN asset group.
Priced in
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
So whatThis write-down directly reduced the book value of assets for the June 30 quarter.
More negative than 70% of claims this week
The company reduced its full-year revenue guidance by approximately 10.8% at the midpoint.
Priced inreported August 5, 2026
So whatLowered top-line expectations will likely compress EPS for the full 2026 fiscal year.
More negative than 70% of claims this week
Which stocks this story touches
More negative than 95% of ticker scores this week
The company is facing a securities fraud investigation following a massive impairment charge and a significant drop in stock price.
More negative than 77% of ticker scores this week
The company is the subject of an investigation into claims on behalf of investors by a law firm.
More negative than 77% of ticker scores this week
The company is the subject of an investigation into claims on behalf of investors by a law firm.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
1h ago
—
EBS hasn't traded since this ran. Last close $6.76 (Sep 22); the reaction starts at the next open.
EBS chart →
